Literature DB >> 22723151

Discriminant and convergent validity of a subjective quality-of-life instrument aimed at high content validity for schizophrenic persons.

M Franz1, M Fritz, T Meyer.   

Abstract

OBJECTIVE: To analyse whether a subjective quality-of-life (QoL) instrument (QLiS-Quality-of-Life in Schizophrenia), developed on the basis of a large number of open-ended interviews with schizophrenic patients, has sufficient discriminant and convergent validity to justify its application as a schizophrenia-specific QoL instrument.
METHOD: The discriminant and convergent validity of the QLiS (comprising 12 subscales) was analysed in a cross-sectional study. Schizophrenic persons (n = 135) from different care settings were surveyed using the QLiS, the WHOQOL-Bref, the SWN and 7-point satisfaction items. Partial correlational analyses and regression analyses controlling for general life satisfaction were conducted comparing the QLiS subscales with those of the other instruments.
RESULTS: Positive correlation coefficients were found among all subscales of the QLiS and the other QoL instruments (WHOQOL-BREF from r = 0.29 to r = 0.72; SWN, r = 0.14 to r = 0.83; satisfaction scales, r = 0.18 to r = 0.69). One QLiS subscale (cognitive functioning) was shown to be empirically redundant (r>0.80) to the mental functioning subscale of the SWN. All other subscales proved to have unique variance. The non-QLiS QoL instruments only accounted for substantial amounts of variance (>20% after controlling for global life satisfaction) in the QLiS subscales leading a normal life, appreciation by others, appraisal of accommodation/housing and social contacts. DISCUSSION: Most of the QLiS subscales can be regarded as sufficiently distinct from other QoL instruments, and thus show evidence of discriminant and convergent validity.
CONCLUSION: A subjective QoL questionnaire with high content validity can provide additional empirical information about schizophrenics' QoL not accounted for by other common QoL instruments.

Entities:  

Mesh:

Year:  2012        PMID: 22723151     DOI: 10.1007/s11136-012-0221-8

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  27 in total

Review 1.  Measuring quality of life: methodological issues.

Authors:  M Dijkers
Journal:  Am J Phys Med Rehabil       Date:  1999 May-Jun       Impact factor: 2.159

2.  Responsiveness of subjective quality of life assessment in schizophrenic patients: a quasi-experimental pilot study.

Authors:  M Franz; T Meyer; A Spitznagel; H Schmidt; K Wening; B Gallhofer
Journal:  Eur Psychiatry       Date:  2001-03       Impact factor: 5.361

3.  Validation of a subjective quality of life questionnaire (S.QUA.LA) in schizophrenia.

Authors:  Liliane Nadalet; Frantz-Samy Kohl; Dominique Pringuey; Frédéric Berthier
Journal:  Schizophr Res       Date:  2005-07-01       Impact factor: 4.939

Review 4.  Social outcomes in schizophrenia.

Authors:  Stefan Priebe
Journal:  Br J Psychiatry Suppl       Date:  2007-08

5.  Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group.

Authors: 
Journal:  Psychol Med       Date:  1998-05       Impact factor: 7.723

6.  Needs and quality of life among patients with schizophrenia in five European centres: what is the impact of global functioning scores?

Authors:  Thomas Becker; Morven Leese; Silvia Krumm; Mirella Ruggeri; José Luis Vázquez-Barquero
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-08-17       Impact factor: 4.328

7.  Patient education methods to support quality of life and functional ability among patients with schizophrenia: a randomised clinical trial.

Authors:  Anneli Pitkänen; Maritta Välimäki; Lauri Kuosmanen; Jouko Katajisto; Marita Koivunen; Heli Hätönen; Anita Patel; Martin Knapp
Journal:  Qual Life Res       Date:  2011-06-08       Impact factor: 4.147

8.  Quality of life in schizophrenia: development, reliability and internal consistency of the Lancashire Quality of Life Profile--European Version. EPSILON Study 8. European Psychiatric Services: Inputs Linked to Outcome Domains and Needs.

Authors:  L Gaite; J L Vázquez-Barquero; A Arrizabalaga Arrizabalaga; A H Schene; B Welcher; G Thornicroft; M Ruggeri; E Vázquez-Bourgon; M Pérez Retuerto; M Leese
Journal:  Br J Psychiatry Suppl       Date:  2000

9.  Development and validation of a patient-based health-related quality of life questionnaire in schizophrenia: the S-QoL.

Authors:  P Auquier; M C Simeoni; C Sapin; G Reine; V Aghababian; J Cramer; C Lançon
Journal:  Schizophr Res       Date:  2003-09-01       Impact factor: 4.939

10.  Preference of medicine and patient-reported quality of life in community-treated schizophrenic patients receiving aripiprazole vs standard of care: results from the STAR study.

Authors:  David Taylor; Linda Hanssens; Jean-Yves Loze; Miranda Pans; Gilbert L'Italien; Ronald N Marcus
Journal:  Eur Psychiatry       Date:  2008-04-18       Impact factor: 5.361

View more
  6 in total

1.  QLiS--development of a schizophrenia-specific quality-of-life scale.

Authors:  Michael Franz; Michael Fritz; Bernd Gallhofer; Thorsten Meyer
Journal:  Health Qual Life Outcomes       Date:  2012-06-07       Impact factor: 3.186

Review 2.  Quality of life as patient-reported outcomes: principles of assessment.

Authors:  Monika Bullinger; Julia Quitmann
Journal:  Dialogues Clin Neurosci       Date:  2014-06       Impact factor: 5.986

3.  QLiS-SF: Development of a short form of the quality of life in schizophrenia questionnaire.

Authors:  T Senin; M Franz; M Deuschle; N Bergemann; J Kammerer-Ciernioch; M Lautenschlager; T Meyer
Journal:  BMC Psychiatry       Date:  2017-04-27       Impact factor: 3.630

4.  Relevance of a subjective quality of life questionnaire for long-term homeless persons with schizophrenia.

Authors:  V Girard; A Tinland; J P Bonin; F Olive; J Poule; C Lancon; T Apostolidis; M Rowe; T Greacen; M C Simeoni
Journal:  BMC Psychiatry       Date:  2017-02-17       Impact factor: 3.630

5.  Validation of the Finnish Health Improvement Profile (HIP) with patients with severe mental illness.

Authors:  Camilla Werkkala; Maritta Välimäki; Minna Anttila; Virve Pekurinen; Daniel Bressington
Journal:  BMC Psychiatry       Date:  2020-03-11       Impact factor: 3.630

Review 6.  Health related quality of life in patients having schizophrenia negative symptoms - a systematic review.

Authors:  Chiraz Azaiez; Aurélie Millier; Christophe Lançon; Emilie Clay; Pascal Auquier; Pierre-Michel Llorca; Mondher Toumi
Journal:  J Mark Access Health Policy       Date:  2018-09-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.